Oncology Drug Insights by OmicsX
No Result
View All Result
  • Login
  • Register
PRICING
SUBSCRIBE
No Result
View All Result
Oncology Drug Insights by OmicsX
No Result
View All Result
Home Big Pharma

Takeda Oncology –
Deals and Alliances Insights

Oncology Acquisitions, Deals & Collaboration Strategies

Team OmicsX by Team OmicsX
May 30, 2022
in Big Pharma, Deals / Alliances
499
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Takeda Oncology (Millennium Pharmaceuticals, Inc) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, developing therapies for the treatment of cancer.
In May 2008, Millennium was acquired by Takeda Pharmaceutical for $8.8 billion USD and is operating as an independent wholly owned subsidiary of Takeda.

Global Oncology Intelligence Global Oncology Intelligence

Support authors and subscribe to content

This is premium stuff. Subscribe to read the entire article.

Login if you have purchased

Subscribe

Gain access to over 500+ Updated Articles covering Market Research & Analysis on Drug Development.
Subscribe

Buy Single Article

Unlock this Article and Gain Permanent Access to Read it.
Purchase This Article
Previous Post

Takeda Oncology-
Drug Pipeline Insights – June 2021

Next Post

Approved Oncology Targeting Small Molecule Kinase Inhibitors

Next Post
Approved Oncology Targeting Small Molecule Kinase Inhibitors

Approved Oncology Targeting Small Molecule Kinase Inhibitors

Developed by OmicsX. The entirety of this site is protected by copyright © 2025 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

Developed by OmicsX. The entirety of this site is protected by copyright © 2025 HH BioTechnologies Private Ltd.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?